Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +34.35%
#2 Siren Siren +31.73%
#3 OriginTrail OriginTrail +18.20%
#4 Purr Purr +17.28%
#5 龙虾 (Lobster) 龙虾 (Lobster) +12.28%
#6 Ethena Staked ENA Ethena Staked ENA +11.62%
#7 Wrapped XPL Wrapped XPL +11.23%
#8 DigiByte DigiByte +11.00%
#9 Collect on Fanable Collect on Fanable +10.98%
#10 Plasma Plasma +10.85%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Procaps Group S.A. Procaps Group S.A.

Procaps Group S.A.

PROC
Classifica tra le azioni #21710
Procaps Group S.A., established in Luxembourg in 1977, functions as a global... Procaps Group S.A., established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical solutions. The company manufactures and markets branded prescription medications addressing diverse therapeutic needs, including women's health, pain management, dermatological conditions, digestive disorders, growth and development, cardiovascular care, vision health, central nervous system ailments, and respiratory issues. In addition to prescription drugs, Procaps supplies a suite of products for hospital use, encompassing antibiotics, anticoagulants, personal protective equipment, immunosuppressants, oncology treatments, and analgesics. Its consumer healthcare division offers an extensive portfolio of over-the-counter (OTC) products across approximately eight primary therapeutic areas such as gastrointestinal health, skincare, cough and cold remedies, pain relievers, urological support, and a variety of vitamins, minerals, and dietary supplements. These offerings cover specific categories like anti-infectives, cardiovascular health, hormonal treatments, metabolic and endocrine support, nervous system medications, ophthalmic solutions, osteoarticular products, and more. Complementing its drug offerings, Procaps provides various diabetes management solutions, including blood glucose meters, telemonitoring devices, oral anti-diabetic medications, cosmeceuticals, and insulin delivery systems. The company also extends its expertise to third-party pharmaceutical companies through contract drug development and manufacturing services, with a particular specialization in soft gelatin capsule technologies.
Prezzo delle azioni
$1.01
Ultima sincronizzazione: 2026-03-12
Capitalizzazione di mercato
$102.08M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-27.86%
Paese
LU
Scambia Procaps Group S.A. (PROC)

Categoria

Healthcare
Il prezzo PROC con la capitalizzazione del mercato della B
Procaps Group S.A. Procaps Group S.A.
PROC
$1.01
Capitalizzazione di mercato di Procaps Group S.A.(PROC)
Capitalizzazione di mercato: $102.08M
A partire dal August 2026, Procaps Group S.A. ha una capitalizzazione di mercato pari a $102.08M. Questo rende Procaps Group S.A. la 21710th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Procaps Group S.A. dal 2019 al 2026
PROC in paragone con la classifica dei più popolari stocks
Il prezzo per PROC Attivo B Capitalizzazione del mercato a B Risultati
Procaps Group S.A. Procaps Group S.A.
$51,560.67 $102.08M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +5,104,916.72%
Procaps Group S.A. Procaps Group S.A.
$44,984.97 $102.08M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,453,857.25%
Procaps Group S.A. Procaps Group S.A.
$41,183.05 $102.08M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +4,077,429.30%
Procaps Group S.A. Procaps Group S.A.
$35,546.65 $102.08M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,519,370.04%
Procaps Group S.A. Procaps Group S.A.
$27,632.17 $102.08M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,735,758.52%